Chapter 3. Impact of Drug Interactions and Adverse Events on Therapeutics

Pharmacotherapeutics for Advanced Practice 3rd Edition by Virginia Poole Arcangelo, Andrew M. Peterson

$2.99

Chapter 3. Impact of Drug Interactions and Adverse Events on Therapeutics

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

MULTIPLE CHOICE

 

  1. Which of the following patients would be at higher risk of experiencing adverse drug reactions (ADRs):
A. A 32-year-old male
B. A 22-year-old female
C. A 3-month-old female
D. A 48-year-old male

 

 

ANS:  C                    PTS:   1

 

  1. Infants and young children are at higher risk of ADRs due to:
A. Immature renal function in school-age children
B. Lack of safety and efficacy studies in the pediatric population
C. Children’s skin being thicker than adults, requiring higher dosages of topical medication
D. Infant boys having a higher proportion of muscle mass, leading to a higher volume of distribution

 

 

ANS:  B                    PTS:   1

 

  1. The elderly are at high risk of ADRs due to:
A. Having greater muscle mass than younger adults, leading to higher volume of distribution
B. The extensive studies that have been conducted on drug safety in this age group
C. The blood-brain barrier being less permeable, requiring higher doses to achieve therapeutic effect
D. Age-related decrease in renal function

 

 

ANS:  D                    PTS:   1

 

  1. The type of adverse drug reaction that is the result of an unwanted but otherwise normal pharmacological action of a drug given in the usual therapeutic doses is
A. Type A
B. Type B
C. Type C
D. Type D

 

 

ANS:  A                    PTS:   1

 

  1. Digoxin may cause a Type A adverse drug reaction due to:
A. Idiosyncratic effects
B. Its narrow therapeutic index
C. Being a teratogen
D. Being a carcinogen

 

 

ANS:  B                    PTS:   1

 

Additional information

Add Review

Your email address will not be published. Required fields are marked *